Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 18.48% of KPRX shares are held by financial institutions. VANGUARD GROUP INC is the top corporate investor, holding 67.21K shares valued at $31.00K. A 0.09% stake in Kiora Pharmaceuticals, Inc. is owned by the company. SUSQUEHANNA INTERNATIONAL GROUP, LLP owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the KPRX insiders holding of 3.08% of the stake in company, FROM STEPHEN, President and CEO, holds the largest shares of 1.03M. ARMISTICE CAPITAL, LLC, 10 percent owner, is the second largest KPRX insider with ownership of 785K shares. WIROSTKO BARBARA, Chief Medical Officer, stands third with possession of 405.53K shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| FROM STEPHEN | President and CEO | 1.03M |
| ARMISTICE CAPITAL, LLC | 10 percent owner | 785K |
| WIROSTKO BARBARA | Chief Medical Officer | 405.53K |
| ROMANO SARAH | Chief Financial Officer | 262.11K |
| MANZO MICHAEL P. | VP of Engineering | 174.8K |
| MANN BRENDA | VP of Research & Development | 174.42K |
| STREM BRIAN M. | President and CEO | 14.53K |
| TOSCA MELISSA | CFO | 13.6K |
| DANIELS ERIC JOSEPH | Chief Development Officer | 11.22K |
| PARSONS ERIN | director | 5.26K |
| TYLE PRAVEEN | director | 5.01K |
| SHAPIRO ARON | director | 3K |
| STENGONE CARMINE N. | director | 1.25K |
| WALTERS-HOFFERT LISA | director | 1.25K |
| GOLDBERG MORTON | director | 0 |
